CSF α-synuclein, tau, and amyloid β in Parkinson's disease - Authors' reply

The Lancet Neurology

Volumn 10, Issue 8, 2011, Pages 681-683

  Mollenhauer, Brit ^a   Schulz Schaeffer, Walter J ^b   Schlossmacher, Michael G ^c  

^a Paracelsus Elena Klinik   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LETTER; LEWY BODY; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

EID: 79960341281     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70161-2     Document Type: Letter

References (10)

1. Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 2011, 10:230-240.
2. Frasier M, Chowdhury S, Eberling J, Sherer T Biomarkers in Parkinson's disease: a funder's perspective. Biomark Med 2010, 4:723-729.
3. Mollenhauer B, Cepek L, Bibl M, et al. Tau protein, Aβ42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dement Geriatr Cogn Disord 2005, 19:164-170.
4. Han H, Weinreb PH, Lansbury PT The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?. Chem Biol 1995, 2:163-169.
5. Galpern WR, Lang AE Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 2006, 59:449-458.
6. Kramer ML, Schulz-Schaeffer WJ Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007, 27:1405-1410.
7. Braak H, de Vos RA, Bohl J, Del Tredici K Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006, 396:67-72.
8. Schulz-Schaeffer WJ The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol 2010, 120:131-143.
9. Tokuda T, Qureshi MM, Ardah MT, et al. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010, 75:1766-1772.
10. Mollenhauer B, Esselmann H, Roeber S, et al. Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease. J Neural Transm 2011, 118:691-697.